You have 9 free searches left this month | for more free features.

Bosutinib

Showing 1 - 25 of 72

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dementia With Lewy Bodies Trial in Washington (Placebo Oral Tablet, Bosutinib Oral Tablet)

Completed
  • Dementia With Lewy Bodies
  • Placebo Oral Tablet
  • Bosutinib Oral Tablet
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
Apr 4, 2022

Condition Vasoregulation Function Endothelium in CML Getting TKI

Recruiting
  • Chronic Myeloid Leukaemia
  • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
  • Moscow, Russian Federation
  • +1 more
Jan 11, 2023

Describe Real World Use of Bosutinib inSingle Centre in Scotland

Completed
  • Myeloid Leukemia
  • Bosutinib
  • Glasgow, United Kingdom
    eatson West of Scotland Cancer Centre
May 3, 2022

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Healthy Participants Trial in Brussels (Bosutinib capsule)

Completed
  • Healthy Participants
  • Bosutinib capsule
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Feb 9, 2022

Healthy Participants Trial in Groningen, Utrecht (Bosutinib capsule, Bosutinib tablet)

Completed
  • Healthy Participants
  • Bosutinib capsule
  • Bosutinib tablet
  • Groningen, Netherlands
  • +1 more
Feb 14, 2022

Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

Completed
  • Leukemia
  • No Intervention
  • Cambridge, Massachusetts
    Takeda
Feb 28, 2023

Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
Jan 17, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Bosutinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib, Ropeginterferon)

Recruiting
  • Chronic Myeloid Leukemia
  • Aalborg, Denmark
  • +17 more
Apr 4, 2022

Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

Completed
  • Leukemia, Chronic Myelogenous
  • Bosutinib
  • Toyoake-City, Aichi, Japan
  • +20 more
Apr 26, 2022

Breast Cancer Trial in Worldwide (Bosutinib, Letrozole)

Terminated
  • Breast Cancer
  • Whittier, California
  • +10 more
Aug 31, 2021

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Bosutinib
  • +4 more
  • Budapest, Hungary
    Pfizer
Dec 15, 2022

Chronic Phase-Chronic Myeloid Leukemia Trial in Madrid (Bosutinib 400 MG Monotherapy, Bosutinib 400 MG + Atezolizumab 840 MG in

Recruiting
  • Chronic Phase-Chronic Myeloid Leukemia
  • Bosutinib 400 MG Monotherapy
  • Bosutinib 400 MG + Atezolizumab 840 MG in 14 ML Injection
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Mar 8, 2021

Safety And Efficacy Of Bosutinib

Recruiting
  • Chronic Myelogenous Leukemia
  • Bosutinib
  • Shibuya-ku, Japan
    (unnamed)
Dec 29, 2020

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Chronic Myeloid Leukemia Trial in Italy (Bosutinib)

Completed
  • Chronic Myeloid Leukemia
  • Bosutinib
  • Alessandria, Italy
  • +44 more
Feb 2, 2023

Amyotrophic Lateral Sclerosis Trial in Japan (Bosutinib)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Bosutinib
  • Kyoto, Japan
  • +3 more
Feb 3, 2021

CML Trial in Brussels (200 Mg capsules of bosutinib in Water solution, bosunitib sorbitol, Bosutinib Mannitol)

Completed
  • CML
  • 200 Mg capsules of bosutinib in Water solution
  • +13 more
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Jul 8, 2020

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Previously Treated PH + CML Trial in Worldwide (Bosutinib)

Terminated
  • Previously Treated PH + CML
  • Bosutinib
  • Los Angeles, California
  • +47 more
Dec 2, 2021